Abstract
A variety of enzymes are activated by the binding of potassium ions. The potassium binding sites of these enzymes are very specific, but ammonium ions can often replace potassium ions in vitro because of their similar ionic radii. In these cases, ammonium can be used as a proxy for potassium to characterise potassium binding sites in enzymes: the 1H,15N spin-pair of enzyme-bound 15NH4+ can be probed by 15N-edited heteronuclear NMR experiments. Here, we demonstrate the use of NMR spectroscopy to characterise binding of ammonium ions to two different enzymes: human histone deacetylase 8 (HDAC8), which is activated allosterically by potassium, and the bacterial Hsp70 homologue DnaK, for which potassium is an integral part of the active site. Ammonium activates both enzymes in a similar way to potassium, thus supporting this non-invasive approach. Furthermore, we present an approach to map the observed binding site onto the structure of HDAC8. Our method for mapping the binding site is general and does not require chemical shift assignment of the enzyme resonances.
Keywords: ammonium, enzyme catalysis, HDAC, Hsp70, NMR spectroscopy, potassium binding
Introduction
Many enzymes are activated by specific binding of one or more monovalent cations (MVCs); these either contribute directly to the catalysis at the active site or indirectly modulate the activity by binding to an allosteric site. Potassium and sodium ions are the most common activating MVCs, with a strong correlation between MVC preference and intracellular (K+) or extracellular (Na+) location of the enzyme.[1] Examples of intracellular, potassium-activated enzymes are the molecular chaperones Hsp70[2] and GroEL[3] (K+ binding at the active sites is crucial for the ATP-dependent reaction cycles), ribokinase (K+ binding near but not at the active site activates the enzyme),[4] and the hydrolase histone deacetylase 8 (HDAC8; binding to two K+ binding sites affects activity).[5] It is generally found that enzymes that are activated by the binding of K+ (ionic radius 1.33 Å) are either not activated or are activated to a lesser extent by Na+ (ionic radius 0.97 Å), and vice versa. However, enzymes that are activated by K+ can often be activated by an MVC of similar ionic radius, such as Rb+ (1.48 Å) or NH4+ (1.44 Å).[6] In some cases it has even been possible to engineer a potassium-independent enzyme by introducing a lysine residue in such a way that its terminal R-NH3+ occupies the binding site, thereby taking the place of the regulatory potassium ion.[7]
Using NH4+ as a proxy for K+ offers the opportunity to characterise potassium binding sites by NMR spectroscopy, as isotopically labelled 15NH4+ is readily available and can be employed in combination with conventional heteronuclear solution-state NMR experiments. The use of 15NH4+ as a K+ mimic has been reported previously for the characterisation of potassium binding sites of DNA quadruplexes[8] by NMR spectroscopy. However, the previously investigated DNA quadruplexes are relatively small compared to many enzymes, and quadruplexes also exhibit highly symmetric MVC binding sites. It is therefore not immediately obvious that the approach of using 15NH4+ to probe potassium binding sites will also be applicable to larger, potassium-dependent enzymes.
Herein we show that 15NH4+ can be used to probe K+ binding sites in medium-sized enzymes (>40 kDa) by NMR spectroscopy. The technique is facilitated by local reorientation and cross-correlated relaxations of the symmetric 15NH4+ molecule within its binding site; this results in line-narrowing of the 15N and 1H resonances, thereby improving the sensitivity of heteronuclear NMR experiments. In contrast to other experimental approaches used to probe MVC binding sites in proteins, NMR measurements of 15NH4+ have distinct advantages: 1) these probe the binding of the MVC directly, not indirectly (e.g., by enzyme activity or stability); 2) they have a high spatial resolution (in contrast to, for example, fluorescence spectroscopy); 3) they cause relatively little perturbation (unlike site-directed mutagenesis-based experiments); and 4) they are suitable for monitoring weak binding events (up to the high mm range), where other methods to study MVC binding (e.g., isothermal titration calorimetry) have limitations.[9]
The critical point is that the binding of 15NH4+ to an MVC binding site can decrease the exchange of the ammonium protons with the bulk solvent to such an extent that these become observable even under conditions where free 15NH4+ in solution is undetectable in proton–nitrogen-correlated experiments because of rapid exchange with the solvent.
For the HDAC8 enzyme, we first show that ammonium and potassium regulate the activity similarly, thus supporting the use of 15NH4+ as a proxy for K+. Using 15N-edited NMR methods, we probed the binding of 15NH4+ to one of the potassium binding sites of HDAC8 and to two potassium binding sites of the bacterial Hsp70 homologue DnaK. Furthermore, we developed a strategy for mapping potassium binding sites within protein structures that does not require a protein chemical shift assignment. The strategy relies on selective isotope labelling, and utilises through-space NOE measurements between 15NH4+ protons and residue-specific side-chain protons.
Results and Discussion
Binding of ammonium to HDAC8
The 42 kDa human HDAC8 enzyme is activated by the binding of potassium ions.[5] In addition to the catalytically important Zn2+ ion at the active site, crystal structures of HDAC8 reveal two MVC binding sites (Figure 1 A–C), as has been observed in most structurally characterised HDACs and HDAC-related deacetylases.[10] Biochemical characterisation[5] and computational approaches[11] have highlighted the importance of potassium binding for activity and potentially even for regulation of this enzyme. Specifically, the effect of KCl concentration on HDAC8 activity was investigated by Fierke and co-workers using HDAC8 with two different divalent metal ions (Co2+ and Zn2+) bound at the active site.[5] These experiments revealed a bell-shaped activity profile, with an activating effect at lower concentrations of K+ and an inactivating effect as the concentration was increased. The resulting activation (K1/2,act) and inhibition (K1/2,inhib) constants, which describe the apparent dissociation constants for an activating and an inhibiting binding site, respectively, were K1/2,act=14 mm and K1/2,inhib=130 mm for Zn2+-bound HDAC8.
In order to test whether NH4+ is a good mimic of K+ for enzyme activation, we measured the deacetylase activity of HDAC8 as a function of NH4+, K+ and choline concentration. Choline was used as a negative control to detect any possible nonspecific influence of ionic strength on HDAC8 activity. For K+ and NH4+ the activity profiles were bell-shaped (Figure 1 D), similar to those reported previously, whereas addition of choline had only a very small effect on HDAC8 activity. NH4+ activation of HDAC8 was ∼60 % of that of K+, with comparable K1/2,act (compare the curves in Figure 1 D), thus suggesting that NH4+ effectively mimics K+ in modulating the activity of HDAC8.
Next, we tested whether it was possible to observe binding of 15NH4+ to HDAC8 by NMR. As expected, bulk 15NH4+ was not observed in 15N-edited, proton-detected 1D NMR spectra in buffer containing 200 mm 15NH4+ at pH 8.0 (Figure 2 A) because of rapid exchange of the ammonium protons with the bulk solvent. The 15N chemical shift of the free ammonium was therefore determined by direct 15N-detection to be 20.5 ppm (Figure 2 A, inset). Addition of [14N]HDAC8, however, resulted in a distinct peak in the 15N-edited experiment, indicative of HDAC8-bound 15NH4+ with a proton chemical shift of 7.1 ppm (Figure 2 B). A 15N chemical shift of 25.5 ppm was subsequently determined by recording a 2D 1H,15N HSQC spectrum (Figure 2 C).
The 15N line-width of 15NH4+ at 298 K bound to HDAC8 (42 kDa) would be expected to be ∼45 Hz, with the 15N nucleus relaxed principally by dipolar interactions with its four protons, with a rotational correlation time of approximately 25 ns. The observation of a peak in the 15N-edited spectra, shifted from the position for free ammonium, shows that binding of the 15NH4+ ion to HDAC8 is sufficiently strong to significantly limit exchange of the ammonium protons with the bulk solvent. Although cross-correlated relaxations within the 15NH4+ molecule cause line-narrowing, the experimental line-width (∼25 Hz), which also includes contributions from the residual proton exchange and proton R1, indicates that the ammonium ion is undergoing local reorientation within the binding site. The spectral parameters obtained from the peak in the 15N-edited spectrum report directly on 15NH4+ in the MVC binding site, with the intensity of this peak directly related to the amount of 15NH4+ bound to HDAC8, thus allowing an estimation of the dissociation constant.
Proton-detected, 15N-edited 1D spectra were recorded for a titration of HDAC8 with 15NH4+, and the resulting 15NH4+ peak integrals were used to determine the dissociation constant for binding of 15NH4+ to HDAC8 (KD=(13±8) mm; Figure 2 D). Addition of 100 mm KCl to a sample containing 100 mm 15NH4+ led to a reduction (∼50 %) in the 15NH4+ integral, thus indicating both that NH4+ and K+ compete for the same binding site and that they bind to this site with similar affinities (Figure 2 D). We therefore conclude that NH4+ binds to at least one of the two K+ binding sites in HDAC8. Binding of NH4+ to this site decreased proton-exchange with the solvent to such an extent that it was observable in 1H,15N-correlated experiments, under conditions where bulk NH4+ cannot be detected. The change in 15N chemical shift upon binding (Δδ=5 ppm) indicates a significant change in the chemical environment, and given the different natures of the two potassium binding sites in HDAC8 (see below and Figure 1 C), it is unlikely that both the proton and 15N chemical shifts of the two HDAC8-bound ammonium ions would be so similar as to lead to overlap of the corresponding peaks in the 1H,15N-correlated spectra. We propose instead that HDAC8 binds a second NH4+—as it binds a second K+—but that this second site does not protect the bound NH4+ from solvent proton exchange sufficiently to be detectable in our experiments.
Binding of ammonium to DnaK
Another example of a potassium-binding enzyme is the molecular chaperone Hsp70. Two potassium ions in the ATP-binding domain (Figure 3 A) have been identified to be crucial for the ATPase cycle,[6b] which in turn regulates the binding and release of substrate proteins.[13] In a similar way to that for HDAC8, these potassium ions can be replaced by ammonium, thereby resulting in approximately half of the ATPase activity observed with potassium.[6b] Based on our success in characterising the potassium binding sites of HDAC8 with 15NH4+, we tested the general applicability of our approach by probing the potassium binding sites of the 41 kDa ATP-binding domain of DnaK, a bacterial Hsp70 homologue from Thermus thermophilus.
Unlike for the experiments with HDAC8, addition of nucleotide-free DnaK ATP-binding domain (DnaK-ABD) to a 15NH4Cl-containing buffer gave only a very weak signal in 15N-edited proton-detected and 1H,15N correlation spectra. The signal was barely above the noise level (Figure 3 B, Figure S1B in the Supporting Information), thus suggesting either that 15NH4+ binds only weakly to nucleotide-free DnaK-ABD, or that the binding sites are solvent-exposed and do not shield the ammonium protons from exchange with bulk solvent (Figure S1). Interestingly, addition of ADP and Pi resulted in the appearance of two clear peaks (Figure 3 B). The 15N chemical shifts of both these peaks (19.3 and 21.9 ppm) are different from the 15N chemical shift that we observed for free ammonium in this buffer when using a direct-detect 15N experiment (20.6 ppm). Our interpretation of these results is that binding of ADP and Pi protects the ammonium protons from solvent exchange, by themselves blocking solvent molecules and/or by inducing a conformational change that decreases solvent accessibility. Both effects agree well with molecular models of nucleotide binding to Hsp70, and it is likely that a combination of both leads to the increased protection of ammonium ions.[2, 14]
To verify that the two resonances observed in Figure 3 B report on two different sites, we recorded 15N-edited NOESY experiments (Figure S3). In the resulting 15N-edited NOESY spectrum, the two resonances gave rise to very different sets of cross-peaks, thus confirming that the resonances report on two different sites in the protein, in agreement with the observation of two different potassium binding sites in the crystal structures of Hsp70 chaperones.
Mapping the MVC binding sites
The ammonium protons bound in a protein environment are close to protons of nearby amino acid side chains; this proximity serves as a potential means for mapping the MVC binding site within the protein structure. The key restraints used for protein structure determinations are nuclear Overhauser enhancements (NOEs) between protons, where the intensity of the observed NOE is approximately proportional to r−6 (r is the distance between the two interacting protons). Similarly, NOEs between bound ammonium protons and protein side-chain protons report on the location of the MVC binding site.
A 15N-edited NOESY experiment was performed to identify side chains in the vicinity of the observed MVC binding site of HDAC8. The resulting spectrum shows a number of NOE crosspeaks between the HDAC8-bound ammonium and the aliphatic side chains, as well as between the ammonium and the amide protons (Figure 4). For proteins where a full chemical shift assignment is available, the binding site is readily mapped from the chemical shifts of the NOE cross-peaks. However, for HDAC8, as well as many other enzymes of interest, a full chemical shift assignment is not available, so alternative approaches must be used. Site-directed mutagenesis and mutation of K+-binding side chains might be an initial and intuitive approach. However, such an approach fails for HDAC8, as the potassium is mostly coordinated by the protein backbone, and also because mutation of side chains that do participate in the coordination of K+ (S199 and D176, see Figure 1 C)[15] resulted in insufficient purified protein for further NMR characterisation. Generally, identification of MVC binding sites by sitedirected mutagenesis could prove difficult, as such sites are either close to the active site or in allosteric regions of the enzyme. Site-directed mutagenesis therefore easily leads to large perturbations of the protein environment. We therefore prefer a non-invasive approach (described below) that is based on residue-specific isotope labelling.
Inspection of the two potassium binding sites in the HDAC8 crystal structure revealed different distributions of amino acids in the immediate vicinities of the two binding sites. Whereas the binding site close to the active site (here termed “site 1”) is surrounded by histidines (Figure 1 B and Figure 4) and leucines, these amino acids are not found in the vicinity of site 2. We therefore produced HDAC8 that was selectively protonated at histidine side chains, by adding 1H,15N-labelled histidine in an otherwise fully 2H,14N background. Histidine is at the end of a biosynthetic pathway and therefore little scrambling with other amino acids is expected.[16] This is confirmed by the fact that we observed a maximum of 11 cross-peaks in the amide region of a 1H,15N HSQC spectrum of this sample, compared to 13 histidines in HDAC8 (Figure S4). Although a specifically histidine-labelled sample has aliphatic protons only in the histidine side chains, additional protons are present at exchangeable sites, such as unprotected backbone amides. To account for exchangeable protons introduced by the H2O buffers, we expressed and purified a sample (U-15N,2H) in the same deuterated background and without the addition of protonated histidine. By comparing the results of the subsequent NOESY experiments (Figure 4), we could clearly identify several cross-peaks originating from histidine side chains. This demonstrates that the observed NH4+ binds to site 1, and thus we were able to assign the observed K+/NH4+ binding site in HDAC8 even in the absence of a full chemical shift assignment.
In general, identification and assignment of MVC binding sites is possible provided that 1) the corresponding 15NH4+ is sufficiently protected from solvent exchange that a signal is observed in 15N-edited NMR spectra, and 2) the MVC binding sites of interest have different local distributions of amino acids.
Conclusions
We successfully used 15NH4+ to characterise a K+ binding site in the 42 kDa enzyme HDAC8 by NMR spectroscopy. By using 15NH4+ instead of K+, we could employ NOESY experiments in combination with selective amino acid labelling of the protein to probe the immediate vicinity of the binding site and map it onto the HDAC8 structure. These experiments have advantages over other means of characterising potassium binding sites in proteins. Firstly, these experiments map the potassium binding sites with minimal perturbation. As HDAC8 has two binding sites for potassium and these are connected by one β-strand, one would expect perturbations of these sites to have mutual effects on each other. Chemical shift perturbations upon titrating with K+ or assays based on site-directed mutagenesis could therefore lead to ambiguous results. The assignment of the sites by 15NH4+-detected NOESY spectra does not suffer from such ambiguity. Secondly, this strategy does not rely on an available chemical shift assignment for the protein, and is generally applicable provided a crystal structure is known and the amino acid compositions of the binding sites in question are different. And thirdly, most of the experiments presented here do not require isotopically labelled protein samples and are therefore relatively cost-effective compared to many other experiments involving NMR spectroscopy.
The bell-shaped activity profile and the presence of two MVC binding sites in crystal structures of HDAC8 led to a model of one activating and one deactivating K+ binding site. Combination of this model with site-directed mutagenesis experiments has led to the proposition that occupation of the K+ binding site close to the active site (site 1) is deactivating, whereas occupation of the second site (site 2) is activating.[5] Our results, however, suggest that site 1 is occupied even at relatively low concentrations of K+ (15NH4+ KD ≈13 mm), that is, in the concentration range of enzyme activation. Recently, we were able to show that binding of potassium has an effect on the structural integrity of HDAC8 in a similar concentration range (K+ KD≈42 mm) as probed by an arginine side chain close to site 2 (∼12 Å from site 2, 21 Å from site 1).[17]
Based on these findings, we therefore propose that both potassium binding sites are important for the stabilisation and activation of the enzyme, and we speculate that the deactivating effect at higher potassium concentrations could result from secondary effects, such as that of high ionic strength on KM or inhibition by high concentrations of chloride.[6a]
In a second example, we monitored ammonium binding to the 41 kDa ATP binding domain of the Hsp70 chaperone DnaK. After addition of ADP and Pi, we observed two crosspeaks in the 1H,15N HSQC spectrum, in agreement with the two potassium ions observed in the crystal structure of Hsp70 with ADP and Pi. These results are in agreement with previous findings of a closed and less solvent-accessible active site in response to nucleotide binding.[14a]
Overall, we detected three potassium binding sites in two proteins by using 15NH4Cl and 15N-edited NMR spectra. The observed chemical shifts range from 6.8 to 7.5 ppm in the 1H dimension and from 19 to 25.5 ppm in the 15N dimension. The level of dispersion suggests that this approach can be used to observe and identify multiple potassium binding sites in even large proteins, where the relaxation properties might be improved by cross-correlated relaxations and local reorientation of the 15NH4+ ion within the binding site.
The methodology presented above could be further exploited by combination with the powerful array of existing NMR techniques to describe the kinetic and dynamic aspects of MVC binding. For example, employing longitudinal exchange-type experiments would allow measurement of the exchange on the millisecond-to-second timescale between two or more bound MVCs, or the exchange of bound MVCs with those from the bulk solvent, as has been shown in the context of DNA quadruplex structures.[8b] The latter experiment depends on detection of bulk ammonium and thus requires a low pH (e.g., pH 5.0),[8b] which might prove a limitation for many proteins. It would also be intriguing to shed light on the relative mobility of ammonium ions in the binding sites of enzymes, and 15N,1H-relaxation-based experiments could give access to such information in the future. Given this potential, correlating characteristics of 15NH4+ binding with functional enzymatic states, as exemplified here, will ultimately lead to a better understanding of the role of monovalent cations in proteins and enzymes.
Experimental Section
Expression and purification of HDAC8: Recombinant HDAC8 was expressed and purified as described previously.[17] Isotope-labelled samples were prepared from culture grown in M9 minimal medium. For the U-15N,1H sample, the M9 medium was made with 15NH4Cl (1 g L−1). For the U-15N,2H sample, the M9 medium was made up in ∼99 % D2O with 15NH4Cl (1 g L−1) and 2H7-glucose (2.5 g L−1). For the His-15N,1H/U-14N,2H sample, the M9 medium was made up in ∼99 % D2O with 14NH4Cl (1 g L−1) and 2H7-glucose (2.5 g L−1); [15N,1H]histidine (60 mg L−1) was added to the culture 1 h prior to induction. Expression was induced with ZnCl2 (0.2 mm) and isopropyl-β-d-thiogalactopyranoside (1 mm), and growth continued overnight at 21 °C before harvesting. Typical HDAC8 yields were 1–2 mg per litre of M9 culture. All isotopes were purchased from Sigma–Aldrich. Recombinant DnaK-ABD (residues 1–381 of Thermus thermophilus DnaK) was expressed in 2YT medium from BL21(DE3) cells and purified essentially as described previously for DnaK.[18] The yield was approximately 30 mg per litre of 2YT culture. The nucleotide content (∼2 %) of the preparation was determined by HPLC analysis.
Activity assay: HDAC8 activity was measured by a modified fluorescence-based assay.[19] The substrate analogue Boc-Lys(Ac)-7-amino-4-methylcoumarin (MAL) was synthesised according to Hoffmann et al.[20] and kindly provided by Christopher Matthews and Charles Marson (UCL, London). The deacetylation reaction was performed in Tris⋅HCl (25 mm, pH 8.0) with different concentrations of KCl, NH4Cl and choline chloride. HDAC8 (0.4 μm) was added to these buffers and incubated for at least 30 min at room temperature. It should be noted that this addition introduced KCl (final concentration 1.5 mm) from the enzyme stock. The reaction was started by adding substrate (200 μm), and quenched after 30 min at 25 °C by addition of an equal volume of developer solution (trypsin (10 mg mL−1) and trichostatin A (4 μm) in Tris⋅HCl (50 mm pH 8.0), NaCl (137 mm), KCl (2.7 mm), MgCl2 (1 mm), PEG (10 %, avg. 8000 Da) and BSA (1 mg mL−1)). After incubation at room temperature for 30 min, the degree of relative deacetylation was quantified in a FLUOstar Optima plate reader (excitation: 380 nm, detection: 460 nm; BMG Labtech, Aylesbury, UK).
NMR experiments: Unless indicated otherwise, samples for NMR experiments were prepared in Tris⋅HCl (25 mm, pH 8.0), with TCEP (0.5 mm), NaN3 (1 mm) and 15NH4Cl (200 mm). The spectra presented in Figure 2 and 3 were measured with an external D2O reference insert (Wilmad coaxial insert Z278513 (Sigma–Aldrich)), in which case no D2O was added to the sample buffer. Otherwise, NMR buffer contained 10 % D2O. Protein concentrations were 0.1–0.3 mm. All 15N-edited proton 1D spectra and the direct-observed 15N 1D spectra were recorded at 298 K on a 500 MHz Avance III spectrometer (Bruker) equipped with a room temperature, inverse, triple-resonance probe. The pulse sequence for the 15N-edited proton 1D spectra was based on the first increment of the fast 15N HSQC sequence.[21] The 15N carrier frequency was at 25 ppm. 15N-edited NOESY spectra were recorded at 298 K on a 700 MHz Avance III spectrometer (Bruker) equipped with a cryogenic inverse triple-resonance probe. The pulse sequence for the NOESY spectra was based on a standard NOESY/15N HSQC sequence,[22] with ammonium selectivity achieved by a shaped IBurp1 nitrogen pulse (1714 μs, centred at 25 ppm) in the first INEPT of the 15N HSQC element.[23] Broadband 15N decoupling during the indirect proton chemical shift evolution period was achieved by using an adiabatic smoothed CHIRP pulse (1000 μs, 30 kHz sweep-width, centred at 100 ppm).[24] The NOESY mixing time was 80 ms. Data were processed and visualised by using Topspin (Bruker), nmrDraw[25] and Sparky.[26]
Acknowledgments
We are grateful to Christopher Matthews and Prof. Charles Marson (University College London) for providing chemicals for HDAC activity assays and Dr. Ralf Seidel and Petra Herde (MPI Dortmund) for cloning and purification of DnaK-ABD. We acknowledge the Medical Research Council and the National Institute for Medical Research for access to the 800 MHz spectrometer in the initial characterisation phase of HDAC8. We thank Micha B. A. Kunze (University College London), Prof. Lewis E. Kay and Dr Rina Rosenzweig (University of Toronto) for fruitful discussions. N.D.W. acknowledges FEBS for a long-term postdoctoral fellowship. This research is supported by the Biotechnology and Biological Sciences Research Council (BBSRC). D.F.H. is a BBSRC David Phillips Fellow.
Supporting Information
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
References
- 1.Di Cera E. J. Biol. Chem. 2006;281:1305–1308. doi: 10.1074/jbc.R500023200. [DOI] [PubMed] [Google Scholar]
- 2.Wilbanks SM, McKay DB. J. Biol. Chem. 1995;270:2251–2257. doi: 10.1074/jbc.270.5.2251. [DOI] [PubMed] [Google Scholar]
- 3a.Kiser PD, Lorimer GH, Palczewski K. Acta Crystallogr. Sect. F. 2009;65:967–971. doi: 10.1107/S1744309109032928. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3b.Grason JP, Gresham JS, Widjaja L, Wehri SC, Lorimer GH. Proc. Natl. Acad. Sci. USA. 2008;105 doi: 10.1073/pnas.0807429105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4a.Andersson CE, Mowbray SL. J. Mol. Biol. 2002;315:409–419. doi: 10.1006/jmbi.2001.5248. [DOI] [PubMed] [Google Scholar]
- 4b.Li J, Wang C, Wu Y, Wu M, Wang L, Wang Y, Zang J. J. Struct. Biol. 2012;177 doi: 10.1016/j.jsb.2011.12.010. [DOI] [PubMed] [Google Scholar]
- 5.Gantt SL, Joseph CG, Fierke CA. J. Biol. Chem. 2010;285:6036–6043. doi: 10.1074/jbc.M109.033399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6a.Lin Y, West AH, Cook PF. Biochemistry. 2008;47:10809–10815. doi: 10.1021/bi801370h. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6b.O'Brien MC, McKay DB. J. Biol. Chem. 1995;270 doi: 10.1074/jbc.270.5.2247. [DOI] [PubMed] [Google Scholar]
- 7a.Laughlin LT, Reed GH. Arch. Biochem. Biophys. 1997;348:262–267. doi: 10.1006/abbi.1997.0448. [DOI] [PubMed] [Google Scholar]
- 7b.Wilbanks SM, McKay DB. Biochemistry. 1998;37 doi: 10.1021/bi973046m. [DOI] [PubMed] [Google Scholar]
- 8a.Hud NV, Schultze P, Feigon J. J. Am. Chem. Soc. 1998;120:6403–6404. [Google Scholar]
- 8b.Hud NV, Schultze P, Sklenár V, Feigon J. J. Mol. Biol. 1999;285 doi: 10.1006/jmbi.1998.2327. [DOI] [PubMed] [Google Scholar]
- 8c.Sket P, Plavec J. J. Am. Chem. Soc. 2010;132 doi: 10.1021/ja104889t. [DOI] [PubMed] [Google Scholar]
- 9.Pagano B, Mattia CA, Giancola C. Int. J. Mol. Sci. 2009;10:2935–2957. doi: 10.3390/ijms10072935. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Lombardi PM, Cole KE, Dowling DP, Christianson DW. Curr. Opin. Struct. Biol. 2011;21:735–743. doi: 10.1016/j.sbi.2011.08.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Wu R, Wang S, Zhou N, Cao Z, Zhang Y. J. Am. Chem. Soc. 2010;132:9471–9479. doi: 10.1021/ja103932d. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12a.Laskowski RA, Swindells MB. J. Chem. Inf. Model. 2011;51:2778–2786. doi: 10.1021/ci200227u. [DOI] [PubMed] [Google Scholar]
- 12b.Wallace AC, Laskowski RA, Thornton JM. Protein Eng. 1995;8 doi: 10.1093/protein/8.2.127. [DOI] [PubMed] [Google Scholar]
- 13.Klostermeier D, Seidel R, Reinstein J. J. Mol. Biol. 1999;287:511–525. doi: 10.1006/jmbi.1999.2636. [DOI] [PubMed] [Google Scholar]
- 14a.Zhuravleva A, Gierasch LM. Proc. Natl. Acad. Sci. USA. 2011;108:6987–6992. doi: 10.1073/pnas.1014448108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14b.Zhang Y, Zuiderweg ERP. Proc. Natl. Acad. Sci. USA. 2004;101 [Google Scholar]
- 15.Vannini A, Volpari C, Gallinari P, Jones P, Mattu M, Carfí A, De Francesco R, Steinkühler C, Di Marco S. EMBO Rep. 2007;8:879–884. doi: 10.1038/sj.embor.7401047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16a.Lian L-Y, Middleton DA. Prog. Nucl. Magn. Reson. Spectrosc. 2001;39:171–190. [Google Scholar]
- 16b.Fiaux J, Bertelsen EB, Horwich AL, Wüthrich K. J. Biomol. NMR. 2004;29 doi: 10.1023/B:JNMR.0000032523.00554.38. [DOI] [PubMed] [Google Scholar]
- 17.Werbeck ND, Kirkpatrick J, Hansen DF. Angew. Chem. 2013;125:3227–3229. doi: 10.1002/anie.201209385. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Angew. Chem. Int. Ed. 2013;52 [Google Scholar]
- 18.Klostermeier D, Seidel R, Reinstein J. J. Mol. Biol. 1998;279:841–853. doi: 10.1006/jmbi.1998.1816. [DOI] [PubMed] [Google Scholar]
- 19.Wegener D, Wirsching F, Riester D, Schwienhorst A. Chem. Biol. 2003;10:61–68. doi: 10.1016/s1074-5521(02)00305-8. [DOI] [PubMed] [Google Scholar]
- 20.Hoffmann K, Brosch G, Loidl P, Jung M. Pharmazie. 2000;55:601–606. [PubMed] [Google Scholar]
- 21.Mori S, Abeygunawardana C, Johnson MO, Vanzijl PCM. J. Magn. Reson. Ser. B. 1995;108:94–98. doi: 10.1006/jmrb.1995.1109. [DOI] [PubMed] [Google Scholar]
- 22.Marion D, Driscoll PC, Kay LE, Wingfield PT, Bax A, Gronenborn AM, Clore GM. Biochemistry. 1989;28:6150–6156. doi: 10.1021/bi00441a004. [DOI] [PubMed] [Google Scholar]
- 23.Geen H, Freeman R. J. Magn. Reson. 1991;93:93–141. [Google Scholar]
- 24.Fu R, Bodenhausen G. Chem. Phys. Lett. 1995;245:415–420. [Google Scholar]
- 25.Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A. J. Biomol. NMR. 1995;6:277–293. doi: 10.1007/BF00197809. [DOI] [PubMed] [Google Scholar]
- 26. T. D. Goddard, D. G. Kneller, SPARKY 3, University of California, San Francisco.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.